findings across major countries in these regions for a macro-level understanding of the market .
Get the Exemplified Analysis for the Products of Companion diagnostic ( CDx ) @ https :// marketreportscenter . com / reports / 508244 / companion-diagnostics-marketglobal-industry-trends-analysis-and-forecast-2017-2024
Key features of the study :
• This report provides in-depth analysis of the companion diagnostics and provides market size ( US $ Million ) and Cumulative Annual Growth Rate ( CAGR (%)) for the forecast period : 2016 to 2024 , considering 2015 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers , restraints , opportunities , new product launches or approval , regional outlook , and competitive strategy adopted by the leading players
• It profiles leading players in the global companion diagnostics market based on the following parameters company overview , financial performance , product portfolio , geographical presence , distribution strategies , key developments and strategies and future plans
• Key companies covered as a part of this study include Abbott Laboratories , Inc ., Agilent Technologies , Inc ., Danaher Corporation , GE Healthcare , Qiagen N . V ., Roche Diagnostics , Myriad Genetics , Inc ., bioMérieux SA , Illumina , Inc . and Siemens Healthcare
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch , technology upgrades , market expansion , and marketing tactics